Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $197.42 | 11 | 70.0% |
| Food and Beverage | $84.52 | 6 | 30.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $232.25 | 14 | $0 (2023) |
| Astellas Pharma US Inc | $18.28 | 1 | $0 (2021) |
| Exelixis Inc. | $17.66 | 1 | $0 (2017) |
| Pharmacyclics LLC, An AbbVie Company | $13.75 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $63.73 | 4 | PFIZER INC. ($63.73) |
| 2022 | $153.89 | 9 | PFIZER INC. ($153.89) |
| 2021 | $18.28 | 1 | Astellas Pharma US Inc ($18.28) |
| 2019 | $14.63 | 1 | PFIZER INC. ($14.63) |
| 2017 | $31.41 | 2 | Exelixis Inc. ($17.66) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/20/2023 | PFIZER INC. | IBRANCE (Drug) | Education | In-kind items and services | $25.00 | General |
| Category: ONCOLOGY | ||||||
| 09/20/2023 | PFIZER INC. | IBRANCE (Drug) | Education | In-kind items and services | $12.80 | General |
| Category: ONCOLOGY | ||||||
| 05/09/2023 | PFIZER INC. | IBRANCE (Drug) | Education | In-kind items and services | $13.13 | General |
| Category: ONCOLOGY | ||||||
| 03/17/2023 | PFIZER INC. | IBRANCE (Drug) | Education | In-kind items and services | $12.80 | General |
| Category: ONCOLOGY | ||||||
| 12/08/2022 | PFIZER INC. | IBRANCE (Drug) | Education | In-kind items and services | $31.20 | General |
| Category: ONCOLOGY | ||||||
| 12/08/2022 | PFIZER INC. | IBRANCE (Drug) | Education | In-kind items and services | $12.80 | General |
| Category: ONCOLOGY | ||||||
| 11/09/2022 | PFIZER INC. | IBRANCE (Drug) | Education | In-kind items and services | $31.80 | General |
| Category: ONCOLOGY | ||||||
| 11/09/2022 | PFIZER INC. | IBRANCE (Drug) | Education | In-kind items and services | $12.80 | General |
| Category: ONCOLOGY | ||||||
| 11/09/2022 | PFIZER INC. | INLYTA (Drug) | Food and Beverage | In-kind items and services | $8.71 | General |
| Category: ONCOLOGY | ||||||
| 08/01/2022 | PFIZER INC. | IBRANCE (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $6.49 | General |
| Category: ONCOLOGY | ||||||
| 06/29/2022 | PFIZER INC. | IBRANCE (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: ONCOLOGY | ||||||
| 06/29/2022 | PFIZER INC. | IBRANCE (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: ONCOLOGY | ||||||
| 04/20/2022 | PFIZER INC. | IBRANCE (Drug) | Education | In-kind items and services | $12.80 | General |
| Category: ONCOLOGY | ||||||
| 04/14/2021 | Astellas Pharma US Inc | LEXISCAN (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: HOSPITAL AND TRANSPLANT | ||||||
| 06/12/2019 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $14.63 | General |
| Category: ONCOLOGY | ||||||
| 10/19/2017 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: Oncology | ||||||
| 06/14/2017 | Exelixis Inc. | Cabometyx (Drug) | Education | In-kind items and services | $17.66 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 2 | 75 | 84 | $11,372 | $2,946 |
All Medicare Procedures & Services
2 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 35 | 41 | $6,642 | $1,911 | 28.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 40 | 43 | $4,730 | $1,035 | 21.9% |
About Dr. Sherri Durica, M.D
Dr. Sherri Durica, M.D is a Hematology & Oncology healthcare provider based in Norman, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1548212186.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sherri Durica, M.D has received a total of $281.94 in payments from pharmaceutical and medical device companies, with $63.73 received in 2023. These payments were reported across 17 transactions from 4 companies. The most common payment nature is "Education" ($197.42).
As a Medicare-enrolled provider, Durica has provided services to 75 Medicare beneficiaries, totaling 84 services with total Medicare billing of $2,946. Data is available for 1 year (2020–2020), covering 2 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Location Norman, OK
- Active Since 05/16/2006
- Last Updated 04/28/2014
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1548212186
Products in Payments
- IBRANCE (Drug) $208.91
- LEXISCAN (Drug) $18.28
- Cabometyx (Drug) $17.66
- XTANDI (Drug) $14.63
- Imbruvica (Drug) $13.75
- INLYTA (Drug) $8.71
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.